Omeprazol Sandoz Care (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Sandoz Care, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related conditions in adults and children.

GNH USA supplies Omeprazol Sandoz Care as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Sandoz Care is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors. - Eradication therapy adjunct: enhances effectiveness of antibiotics in Helicobacter pylori regimens. - NSAID‑induced ulcer prevention: lowers risk of ulcer formation in patients requiring long‑term NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools, often transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Acute interstitial nephritis: kidney inflammation with reduced urine output. - Hypomagnesemia: low serum magnesium causing muscle cramps or arrhythmia. - Stevens‑Johnson syndrome: severe skin and mucosal reactions. - Liver enzyme elevation: increased ALT/AST levels indicating hepatic stress. - Fracture risk: possible reduction in bone mineral density with long‑term use.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be required in severe impairment. - Review hepatic status: use with caution in patients with liver disease. - Evaluate concomitant medications: potential for drug‑drug interactions. - Pregnancy and lactation: weigh benefits against potential risks; consult a prescriber. - Long‑term use: monitor for vitamin B12 deficiency and bone health. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular event risk. - Atazanavir: decreased absorption leading to therapeutic failure. - Dasatinib: lowered plasma concentrations, compromising efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent monitoring. - Phenytoin: enhanced metabolism may reduce seizure control. - Methotrexate: elevated levels can increase toxicity risk. - Digoxin: increased serum concentrations may cause toxicity. - Ketoconazole: reduced absorption, diminishing antifungal activity.